Research for the Development of an Integrated Medical System for Idiopathic Pulmonary Fibrosis: Based on an Analysis of Questionnaire Survey in Doctor and Patient Groups

Objective: In this study, a questionnaire survey was conducted for doctors and patients to obtain basic data necessary the development of an integrated medical system idiopathic pulmonary fibrosis (IPF).Methods: Questionnaires were developed separately through expert group meeting. The subjects recruited online offline, finally, responses from 231 59 used statistical analysis.Results: most important parts in treatment IPF both “improvement respiratory symptoms,” quality life,” “prevention disease progression.” Antifibrotic agents prescribed at high rate, 100% specialists Western medicine (WM) 45.8% reported experiencing side effects. As additional payment costs that considered as affordable system, “under 50,000 won (about 38$)” doctor patient groups. With regard reasons their reluctance recommend IPF, WM responded highly “uncertain evidence effectiveness.” Regarding complementary alternative therapies can be beneficial with “lifestyle management,” “diet “herb,” “relaxation therapy,” “psychotherapy” ranked groups.Conclusions: on review actual status, analyze shortcomings, identify considerations future.